|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0456 USD | -17.09% |
|
-33.53% | -25.73% |
| 11-14 | CV Sciences, Inc., Q3 2025 Earnings Call, Nov 13, 2025 | |
| 11-14 | CV Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
| Capitalization | 11.31M 9.72M 8.78M 8.41M 15.36M 1.04B 15.84M 103M 41.42M 498M 42.46M 41.56M 1.78B | P/E ratio 2023 |
1.77x | P/E ratio 2024 | -2.48x |
|---|---|---|---|---|---|
| Enterprise value | 11.64M 9.99M 9.03M 8.65M 15.8M 1.07B 16.3M 106M 42.61M 513M 43.68M 42.75M 1.83B | EV / Sales 2023 |
0.29x | EV / Sales 2024 | 0.42x |
| Free-Float |
99.98% | Yield 2023 * |
-
| Yield 2024 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | -17.09% | ||
| 1 week | -33.53% | ||
| Current month | -46.42% | ||
| 1 month | +25.27% | ||
| 3 months | +76.06% | ||
| 6 months | +36.94% | ||
| Current year | -25.73% |
| 1 week | 0.05 | 0.08 | |
| 1 month | 0.04 | 0.1 | |
| Current year | 0.04 | 0.1 | |
| 1 year | 0.02 | 0.1 | |
| 3 years | 0.02 | 0.1 | |
| 5 years | 0.02 | 0.64 | |
| 10 years | 0.02 | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -17.09% | -33.53% | +36.53% | 0.00% | 8.4M | ||
| -0.70% | -0.63% | +20.68% | +217.87% | 895B | ||
| +0.46% | -1.23% | +45.32% | +60.75% | 587B | ||
| -0.19% | -2.93% | +4.78% | +51.63% | 401B | ||
| -2.18% | -8.70% | +10.49% | +23.97% | 345B | ||
| -0.93% | -5.42% | +26.19% | +61.62% | 300B | ||
| -1.31% | -4.14% | +25.99% | +35.35% | 306B | ||
| -0.02% | -2.29% | +22.95% | +8.73% | 289B | ||
| -0.41% | -0.42% | +14.68% | +64.76% | 202B | ||
| +1.32% | +0.49% | +26.75% | +86.87% | 184B | ||
| Average | -2.11% | -5.16% | +23.44% | +61.15% | 351.05B | |
| Weighted average by Cap. | -0.49% | -1.91% | +23.08% | +91.30% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 16M 13.74M 12.42M 11.89M 21.72M 1.47B 22.41M 146M 58.59M 705M 60.06M 58.79M 2.52B | 15.7M 13.49M 12.19M 11.67M 21.32M 1.44B 21.99M 144M 57.49M 692M 58.94M 57.69M 2.48B |
| Net income | 3.1M 2.66M 2.41M 2.31M 4.21M 285M 4.34M 28.36M 11.36M 137M 11.64M 11.39M 489M | -2.39M -2.06M -1.86M -1.78M -3.25M -220M -3.35M -21.89M -8.76M -105M -8.98M -8.79M -377M |
| Net Debt | -875K -751K -679K -650K -1.19M -80.37M -1.23M -8M -3.2M -38.53M -3.28M -3.21M -138M | 325K 279K 252K 242K 441K 29.85M 455K 2.97M 1.19M 14.31M 1.22M 1.19M 51.24M |
Employees
48
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/03/26 | 0.0456 $ | -17.09% | 5,340,937 |
| 09/03/26 | 0.0550 $ | -8.49% | 1,046,388 |
| 06/03/26 | 0.0601 $ | -3.69% | 459,329 |
| 05/03/26 | 0.0624 $ | -9.43% | 2,254,733 |
| 04/03/26 | 0.0689 $ | +0.40% | 1,716,582 |
- Stock Market
- Equities
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















